treatment significantly reduced serum and brain AChE activity, C-reactive protein levels, and monocyte chemoattractant protein-1 levels but significantly increased acetylcholine (ACh) levels in AlCl3-induced AD rats [95]. This evidence concerns the gene ACHE and Alzheimer disease.